INFAHEAL-D

Comprehensive Overview of Advanced Enzyme and Anti-Inflammatory Therapy

Infaheal-D, manufactured by Solvista Healthcare, is a potent multi-ingredient pharmaceutical formulation designed to provide “Advanced Enzyme Power” for the management of severe pain and inflammation. By combining proteolytic enzymes with a reliable non-steroidal anti-inflammatory drug (NSAID) and a bioflavonoid, Infaheal-D offers a synergistic approach to healing that goes beyond simple pain suppression.

Composition and Mechanism of Action

The clinical efficacy of Infaheal-D is rooted in its unique quadruple combination: Trypsin, Bromelain, Rutoside Trihydrate, and Diclofenac Sodium. Each component plays a specific role in the recovery process:

1. Trypsin & Bromelain (Proteolytic Enzymes): These enzymes are essential for “Dual Enzyme Action.” They work by breaking down fibrin clots and dead tissue at the site of injury. This process improves blood circulation to the affected area, reduces edema (swelling), and allows the body’s natural repair mechanisms to function more efficiently. Bromelain, derived from pineapples, is particularly noted for its ability to inhibit pro-inflammatory prostaglandins.
2. Rutoside Trihydrate (Bioflavonoid): Often referred to as Vitamin P, Rutoside acts as a powerful antioxidant. It strengthens the walls of capillaries and reduces their permeability. This prevents the leakage of fluids into surrounding tissues, further controlling swelling and protecting the area from oxidative stress.
3. Diclofenac Sodium (NSAID): This is a well-established analgesic and anti-inflammatory agent. It works by inhibiting the enzyme cyclooxygenase (COX), which reduces the production of prostaglandins responsible for signaling pain and maintaining inflammation.

Key Therapeutic Benefits

The integrated formula of Infaheal-D provides several distinct advantages for patients recovering from trauma or chronic inflammatory conditions:

• Effective Pain Relief: Through Diclofenac Sodium, the tablets provide rapid relief from acute pain, making it easier for patients to maintain mobility.
• Reduced Swelling and Tissue Inflammation: The combination of enzymes and Rutoside attacks the root cause of swelling, promoting the resorption of inflammatory byproducts.
• Faster Recovery from Injury: By clearing debris from the site of trauma and improving microcirculation, the medication significantly shortens the “downtime” associated with sports injuries or accidental trauma.
• Support for Post-Operative and Trauma Care: It is highly suitable for surgical recovery, where managing both tissue trauma and inflammatory pain is critical for successful rehabilitation.

Clinical Applications

Infaheal-D is typically indicated for a variety of conditions, including:

• Post-Surgical Recovery: To minimize post-operative edema and pain.
• Traumatic Injuries: Such as sprains, strains, fractures, and hematomas.
• Joint and Muscle Pain: Managing flare-ups of inflammatory conditions like rheumatoid arthritis or osteoarthritis.
• Dental Procedures: Reducing inflammation following complex extractions or oral surgeries.